Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details)

v3.19.2
Commitments and Contingencies (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Nov. 01, 2018
Mar. 31, 2019
Jun. 30, 2019
CRO      
Commitments and Contingencies      
Expected term 5 years    
CRO Initial clinical trials      
Commitments and Contingencies      
Expected term     2 years
Expected cost     $ 10,000
Cost incurred to date     1,410
CRO Second clinical trials      
Commitments and Contingencies      
Expected term   3 years  
Expected cost   $ 8,000  
Cost incurred     843
Reimbursed cost (as a percent)   50.00%  
Reimbursement receivable     $ 422